Strafford will be offering a webinar entitled "Paragraph IV Litigation and IPRs -- Interplay Between Paragraph IV Litigation and IPRs, Multiple Generic Challengers, Key Issues in IPRs" on April 5, 2018 from 1:00 to 2:30 pm (EDT). Erin M. Dunston, Matthew L. Fedowitz, and Mythili Markowski of Buchanan Ingersoll & Rooney will discuss strategies for using IPRs in relation to Hatch-Waxman litigation, how pharmaceutical patents fare in post-grant challenges in comparison to all patents, and what the crucial issues are in post-grant challenges involving pharmaceutical patents. The webinar will review the following issues:
• Where do multiple generic challengers fit into the exclusivity scheme?
• How do pharma patents and CDER-listed biologic patents fare in post-grant challenges in comparison to all patents?
• What are the crucial issues in post-grant challenges involving pharma or biologics patents?
The registration fee for the webcast is $297. Those interested in registering for the webinar, can do so here.
Comments